Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional 5-FU for Basal Cell Carcinoma
NCT06150144Phase 3Recruiting
- Sponsor
- University of Aleppo
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil in basal cell carcinoma (BCC), sponsored by University of Aleppo. Started May 2023; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT06150144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06150144.